Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: Results of the PANCOSTABRAX study

  1. Carrato, A.
  2. García, P.
  3. Lopez, R.
  4. Macarulla, T.
  5. Rivera, F.
  6. Sastre, J.
  7. Gostkorzewicz, J.
  8. Benedit, P.
  9. Perez-Alcántara, F.
Aldizkaria:
Expert Review of Pharmacoeconomics and Outcomes Research

ISSN: 1744-8379,  1473-7167

Argitalpen urtea: 2015

Alea: 15

Zenbakia: 4

Orrialdeak: 579-589

Mota: Berrikuspena

DOI: 10.1586/14737167.2015.1047349 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus